| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.54e-05 | 20 | 49 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 9.37e-05 | 36 | 49 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF451 ZNF254 ZFHX2 ZNF723 ZNF319 ZNF304 | 1.18e-04 | 1412 | 49 | 12 | GO:0000981 |
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 1.23e-04 | 7 | 49 | 2 | GO:0034988 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF254 ZFHX2 ZNF362 ZNF723 ZNF319 ZNF304 | 1.61e-04 | 1459 | 49 | 12 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SCRT2 ZNF16 ZFAT FEZF2 ZNF655 ZNF254 ZFHX2 ZNF362 ZNF723 ZNF319 ZNF304 | 1.70e-04 | 1244 | 49 | 11 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SCRT2 ZNF16 ZFAT FEZF2 ZNF655 ZNF254 ZFHX2 ZNF362 ZNF723 ZNF319 ZNF304 | 2.06e-04 | 1271 | 49 | 11 | GO:0000987 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 3.54e-04 | 137 | 49 | 4 | GO:0019783 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 1.20e-03 | 21 | 49 | 2 | GO:0034987 | |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | 1.25e-03 | 192 | 49 | 4 | GO:0008234 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 2.76e-03 | 114 | 49 | 3 | GO:0004843 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 2.85e-03 | 398 | 49 | 5 | GO:0061659 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 3.50e-03 | 124 | 49 | 3 | GO:0101005 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 1.47e-04 | 8 | 48 | 2 | GO:0001812 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.89e-04 | 9 | 48 | 2 | GO:0033133 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 1.89e-04 | 9 | 48 | 2 | GO:0001810 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 2.36e-04 | 10 | 48 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 2.36e-04 | 10 | 48 | 2 | GO:0002894 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 2.36e-04 | 10 | 48 | 2 | GO:0001798 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.36e-04 | 10 | 48 | 2 | GO:1903301 | |
| GeneOntologyBiologicalProcess | podocyte development | 2.36e-04 | 10 | 48 | 2 | GO:0072015 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 2.36e-04 | 10 | 48 | 2 | GO:0016068 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 2.88e-04 | 11 | 48 | 2 | GO:0002892 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 2.88e-04 | 11 | 48 | 2 | GO:0001796 | |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | 3.49e-04 | 144 | 48 | 4 | GO:0070646 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 4.07e-04 | 13 | 48 | 2 | GO:0033131 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 4.07e-04 | 13 | 48 | 2 | GO:0001788 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 4.74e-04 | 14 | 48 | 2 | GO:1903299 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 5.46e-04 | 15 | 48 | 2 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 5.46e-04 | 15 | 48 | 2 | GO:0001794 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 5.46e-04 | 15 | 48 | 2 | GO:0002445 | |
| GeneOntologyBiologicalProcess | protein sumoylation | 6.05e-04 | 71 | 48 | 3 | GO:0016925 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 7.05e-04 | 17 | 48 | 2 | GO:0002866 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.37e-04 | 8 | 47 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 2.20e-04 | 10 | 47 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 4.43e-04 | 14 | 47 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 4.43e-04 | 14 | 47 | 2 | GO:0071735 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 6.59e-04 | 17 | 47 | 2 | GO:0042571 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 7.40e-04 | 18 | 47 | 2 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 9.16e-04 | 20 | 47 | 2 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.01e-03 | 21 | 47 | 2 | GO:0106068 | |
| GeneOntologyCellularComponent | lamellipodium membrane | 1.11e-03 | 22 | 47 | 2 | GO:0031258 | |
| MousePheno | abnormal morula morphology | 3.00e-05 | 26 | 33 | 3 | MP:0012058 | |
| MousePheno | absent memory B cells | 3.23e-05 | 4 | 33 | 2 | MP:0008094 | |
| MousePheno | failure of blastocyst formation | 5.15e-05 | 31 | 33 | 3 | MP:0012129 | |
| MousePheno | abnormal blastocyst formation | 1.03e-04 | 39 | 33 | 3 | MP:0012128 | |
| MousePheno | decreased memory B cell number | 1.93e-04 | 9 | 33 | 2 | MP:0008729 | |
| MousePheno | abnormal germinal center B cell number | 2.89e-04 | 55 | 33 | 3 | MP:0013680 | |
| MousePheno | abnormal germinal center B cell morphology | 2.89e-04 | 55 | 33 | 3 | MP:0008176 | |
| MousePheno | decreased IgG2c level | 2.93e-04 | 11 | 33 | 2 | MP:0008897 | |
| MousePheno | abnormal memory B cell number | 2.93e-04 | 11 | 33 | 2 | MP:0008093 | |
| MousePheno | abnormal memory B cell morphology | 4.83e-04 | 14 | 33 | 2 | MP:0002440 | |
| MousePheno | abnormal plasma cell differentiation | 5.57e-04 | 15 | 33 | 2 | MP:0008099 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 6.35e-04 | 16 | 33 | 2 | MP:0003701 | |
| MousePheno | enhanced humoral immune response | 7.19e-04 | 17 | 33 | 2 | MP:0020155 | |
| MousePheno | decreased immunoglobulin level | 7.95e-04 | 315 | 33 | 5 | MP:0002460 | |
| Domain | Znf_C2H2-like | ZNF462 SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF451 ZNF254 ZFHX2 ZNF622 ZNF362 ZNF319 ZNF304 | 3.92e-09 | 796 | 46 | 14 | IPR015880 |
| Domain | Znf_C2H2 | ZNF462 SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF451 ZNF254 ZFHX2 ZNF622 ZNF362 ZNF319 ZNF304 | 4.53e-09 | 805 | 46 | 14 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF462 SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF451 ZNF254 ZFHX2 ZNF622 ZNF362 ZNF319 ZNF304 | 4.75e-09 | 808 | 46 | 14 | SM00355 |
| Domain | zf-C2H2 | ZNF462 SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF451 ZNF254 ZFHX2 ZNF362 ZNF319 ZNF304 | 7.42e-09 | 693 | 46 | 13 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF462 SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF451 ZNF254 ZFHX2 ZNF362 ZNF319 ZNF304 | 2.80e-08 | 775 | 46 | 13 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF462 SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF451 ZNF254 ZFHX2 ZNF362 ZNF319 ZNF304 | 2.89e-08 | 777 | 46 | 13 | PS00028 |
| Domain | - | ZNF462 SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF254 ZFHX2 ZNF362 ZNF319 ZNF304 | 6.05e-08 | 679 | 46 | 12 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF462 SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF254 ZFHX2 ZNF362 ZNF319 ZNF304 | 7.68e-08 | 694 | 46 | 12 | IPR013087 |
| Domain | C1-set | 3.18e-04 | 54 | 46 | 3 | PF07654 | |
| Domain | IGc1 | 3.54e-04 | 56 | 46 | 3 | SM00407 | |
| Domain | Ran_BP1 | 3.86e-04 | 12 | 46 | 2 | PF00638 | |
| Domain | RANBD1 | 3.86e-04 | 12 | 46 | 2 | PS50196 | |
| Domain | Ig_C1-set | 3.92e-04 | 58 | 46 | 3 | IPR003597 | |
| Domain | RanBD | 4.55e-04 | 13 | 46 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 4.55e-04 | 13 | 46 | 2 | IPR000156 | |
| Domain | ZnF_U1 | 2.31e-03 | 29 | 46 | 2 | SM00451 | |
| Domain | Znf_U1 | 2.31e-03 | 29 | 46 | 2 | IPR003604 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF462 USP34 ZNF16 RANBP2 SENP1 ZNF142 USP42 ZNF655 ZNF451 LAMB2 ZNF362 ZNF319 | 7.85e-08 | 1203 | 49 | 12 | 29180619 |
| Pubmed | 4.30e-07 | 11 | 49 | 3 | 27566940 | ||
| Pubmed | Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains. | 1.16e-05 | 4 | 49 | 2 | 6283537 | |
| Pubmed | Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. | 1.16e-05 | 4 | 49 | 2 | 19703988 | |
| Pubmed | Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain. | 1.16e-05 | 4 | 49 | 2 | 6801765 | |
| Pubmed | Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain. | 1.16e-05 | 4 | 49 | 2 | 113776 | |
| Pubmed | Highly specific anti-estradiol antibodies: structural characterisation and binding diversity. | 1.16e-05 | 4 | 49 | 2 | 11812141 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6794027 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 2878362 | ||
| Pubmed | IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice. | 1.16e-05 | 4 | 49 | 2 | 25867470 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 1542303 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 9725203 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6306571 | ||
| Pubmed | Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains. | 1.16e-05 | 4 | 49 | 2 | 9126488 | |
| Pubmed | Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. | 1.16e-05 | 4 | 49 | 2 | 6767246 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 12051834 | ||
| Pubmed | Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes. | 1.16e-05 | 4 | 49 | 2 | 2510996 | |
| Pubmed | Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection. | 1.16e-05 | 4 | 49 | 2 | 1754385 | |
| Pubmed | Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies. | 1.16e-05 | 4 | 49 | 2 | 19050247 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 1672339 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 8683112 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 8452816 | ||
| Pubmed | Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. | 1.16e-05 | 4 | 49 | 2 | 807855 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 4166666 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 26201558 | ||
| Pubmed | An autoimmune disease variant of IgG1 modulates B cell activation and differentiation. | 1.16e-05 | 4 | 49 | 2 | 30287618 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 7892607 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 4565406 | ||
| Pubmed | Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. | 1.16e-05 | 4 | 49 | 2 | 1713710 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6777755 | ||
| Pubmed | The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses. | 1.16e-05 | 4 | 49 | 2 | 9103199 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6249338 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6804950 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6297797 | ||
| Pubmed | Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses. | 1.16e-05 | 4 | 49 | 2 | 19592272 | |
| Pubmed | Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain. | 1.16e-05 | 4 | 49 | 2 | 98524 | |
| Pubmed | IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. | 1.16e-05 | 4 | 49 | 2 | 25363774 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 10720538 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 4831970 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 7439686 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 20621099 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 38268239 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 24752300 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 15699144 | ||
| Pubmed | Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). | 1.16e-05 | 4 | 49 | 2 | 12414967 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6278424 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 35133976 | ||
| Pubmed | Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains. | 1.16e-05 | 4 | 49 | 2 | 6799207 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 8099342 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6787604 | ||
| Pubmed | Shutdown of class switch recombination by deletion of a switch region control element. | 1.16e-05 | 4 | 49 | 2 | 8438159 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 4098598 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 2513486 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6253932 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 36763580 | ||
| Pubmed | Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation. | 1.16e-05 | 4 | 49 | 2 | 32006024 | |
| Pubmed | Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. | 1.16e-05 | 4 | 49 | 2 | 6769752 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 12209645 | ||
| Pubmed | Independent immunoglobulin class-switch events occurring in a single myeloma cell line. | 1.16e-05 | 4 | 49 | 2 | 3921826 | |
| Pubmed | Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes. | 1.16e-05 | 4 | 49 | 2 | 6803173 | |
| Pubmed | Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain. | 1.16e-05 | 4 | 49 | 2 | 117549 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 116231 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6262729 | ||
| Pubmed | Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid. | 1.16e-05 | 4 | 49 | 2 | 26683050 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6170065 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 25451975 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 6264445 | ||
| Pubmed | Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. | 1.16e-05 | 4 | 49 | 2 | 6766534 | |
| Pubmed | Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma. | 1.94e-05 | 5 | 49 | 2 | 35044826 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 9834201 | ||
| Pubmed | IgG1 cytoplasmic tail is essential for cell surface expression in Igβ down-regulated cells. | 1.94e-05 | 5 | 49 | 2 | 24548411 | |
| Pubmed | Exon shuffling generates an immunoglobulin heavy chain gene. | 1.94e-05 | 5 | 49 | 2 | 6769120 | |
| Pubmed | Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains. | 1.94e-05 | 5 | 49 | 2 | 6770027 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 103631 | ||
| Pubmed | Sequential class switching is required for the generation of high affinity IgE antibodies. | 1.94e-05 | 5 | 49 | 2 | 22249450 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 33163250 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 37310381 | ||
| Pubmed | The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program. | 1.94e-05 | 5 | 49 | 2 | 26620759 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 32640012 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 36853944 | ||
| Pubmed | Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. | 1.94e-05 | 5 | 49 | 2 | 6781756 | |
| Pubmed | Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. | 1.94e-05 | 5 | 49 | 2 | 7704573 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 27167731 | ||
| Pubmed | Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16). | 1.94e-05 | 5 | 49 | 2 | 9743367 | |
| Pubmed | Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4. | 1.94e-05 | 5 | 49 | 2 | 20031218 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 23423996 | ||
| Pubmed | Human and murine immunoglobulin expression vector cassettes. | 1.94e-05 | 5 | 49 | 2 | 11257305 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 32229726 | ||
| Pubmed | Molecular and cellular basis of the retrovirus resistance in I/LnJ mice. | 1.94e-05 | 5 | 49 | 2 | 16301663 | |
| Pubmed | Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation. | 1.94e-05 | 5 | 49 | 2 | 34539636 | |
| Pubmed | The disulphide bridges of a mouse immunoglobulin G1 protein. | 1.94e-05 | 5 | 49 | 2 | 5073237 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 3031474 | ||
| Pubmed | A novel allele for inducible Cre expression in germinal center B cells. | 1.94e-05 | 5 | 49 | 2 | 30359469 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 33025844 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 9707605 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 36779803 | ||
| Pubmed | Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments. | 1.94e-05 | 5 | 49 | 2 | 6798155 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 27457619 | ||
| Pubmed | Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice. | 2.91e-05 | 6 | 49 | 2 | 24589747 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 38438375 | ||
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF462 SCRT2 ZNF16 ZNF142 ZFAT FEZF2 ZNF655 ZNF451 ZNF254 ZFHX2 ZNF362 ZNF319 ZNF304 | 3.61e-10 | 718 | 35 | 13 | 28 |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 4.48e-06 | 367 | 48 | 7 | M41159 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN | 2.59e-05 | 191 | 48 | 5 | M9977 | |
| Disease | common variable immunodeficiency (is_implicated_in) | 1.49e-05 | 4 | 47 | 2 | DOID:12177 (is_implicated_in) | |
| Disease | Combined immunodeficiency | 3.87e-05 | 41 | 47 | 3 | C0494261 | |
| Disease | amyloid plaque accumulation rate | 1.62e-04 | 12 | 47 | 2 | EFO_0007646 | |
| Disease | Omenn Syndrome | 4.17e-04 | 19 | 47 | 2 | C2700553 | |
| Disease | Severe Combined Immunodeficiency | 4.63e-04 | 20 | 47 | 2 | C0085110 | |
| Disease | response to antineoplastic agent | 5.34e-04 | 99 | 47 | 3 | GO_0097327 | |
| Disease | diacylglycerol 34:1 measurement | 6.70e-04 | 24 | 47 | 2 | EFO_0010352 | |
| Disease | diacylglycerol 34:2 measurement | 7.28e-04 | 25 | 47 | 2 | EFO_0010353 | |
| Disease | cholesterol to total lipids in small LDL percentage | 8.50e-04 | 27 | 47 | 2 | EFO_0022241 | |
| Disease | serum IgA measurement | 1.12e-03 | 31 | 47 | 2 | EFO_0004912 | |
| Disease | triacylglycerol 54:3 measurement | 1.12e-03 | 31 | 47 | 2 | EFO_0010421 | |
| Disease | reticulocyte measurement | 1.31e-03 | 1053 | 47 | 7 | EFO_0010700 | |
| Disease | triacylglycerol 52:5 measurement | 1.43e-03 | 35 | 47 | 2 | EFO_0010417 | |
| Disease | triacylglycerol 56:8 measurement | 1.51e-03 | 36 | 47 | 2 | EFO_0010435 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 1.77e-03 | 39 | 47 | 2 | DOID:9744 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.90e-03 | 50 | 47 | 2 | EFO_0022334 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 2.90e-03 | 50 | 47 | 2 | EFO_0022247 | |
| Disease | triglycerides to total lipids in large LDL percentage | 3.01e-03 | 51 | 47 | 2 | EFO_0022331 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DTHIHASSCMNQKHL | 416 | Q01433 | |
| YHLMHKNCNHFSSAL | 101 | Q9BSY9 | |
| HLQLKEKCNSHHSSY | 496 | P49792 | |
| TKTHYHAMHADCLQE | 176 | Q29983 | |
| TCHFNHSSKTFMVIH | 66 | P06858 | |
| YCHSIMEHHHFDQCL | 676 | O76074 | |
| GHTHSCHFDMAVYLA | 351 | P55268 | |
| LSSLNHSYSHSHGMK | 121 | Q9Y608 | |
| ARAYFLSHCHKDHMK | 26 | Q96SD1 | |
| DLCHQVLHHCSSSMD | 1506 | Q8NF50 | |
| SEHKILHDQHCQMSS | 1416 | P49454 | |
| DYQAMCKPSSHHHSA | 936 | Q7Z3S7 | |
| HMFCCVGSQDSYHHA | 156 | Q4VXA5 | |
| AHNATHATYTCHMDV | 71 | Q9HBE5 | |
| HATYTCHMDVFHFMA | 76 | Q9HBE5 | |
| FSCSVMHEALHNHYT | 306 | P01857 | |
| MHEALHNHYTQKSLS | 311 | P01857 | |
| SVMHEALHNHYTQKS | 306 | P01861 | |
| FHMHTHNDKKPFTCA | 406 | Q8TBJ5 | |
| AMSCSSAHLHSRNLH | 976 | Q13615 | |
| QKGMLYHHCSSFCLH | 746 | Q3ZCN5 | |
| TQCYMHNKHELAHAF | 116 | Q96AX9 | |
| LYKTHVISHSYCEHM | 171 | Q8NGK5 | |
| NCYHSATLCMHANTH | 71 | Q9UQF0 | |
| RAHMQTHSAFKHYRC | 256 | Q9NQ03 | |
| HLQLKEKCNSHHSSY | 496 | P0DJD1 | |
| KMSLCHAHHASKVNQ | 1216 | Q5VVP1 | |
| KSNHHCHVSAYEKSF | 136 | Q9P0U3 | |
| HLGMSCHSKTDFCHH | 136 | P08842 | |
| THLHLAEDCMKHYQG | 346 | P61764 | |
| SLHEDMNCFSHSAAH | 646 | Q8N961 | |
| MDHEYPCHHITSHCT | 81 | Q96NS8 | |
| TNHLYTHMTHFLKQC | 741 | Q12884 | |
| EECSKHMSGKNHFHQ | 266 | Q9Y4E5 | |
| MSLASHKFHRYSCAH | 626 | Q9Y4E5 | |
| ANYMLSHEHSKTCHA | 136 | Q9H9J4 | |
| SHEHSKTCHAEGFCM | 141 | Q9H9J4 | |
| AHMNRHSTEKTHLCD | 926 | Q9P243 | |
| HMREKHPESNSHCSY | 471 | Q9C0A1 | |
| SFCMLSHLTKHERNH | 181 | P0DPD5 | |
| HSHHSQMVASSACLS | 471 | Q86V40 | |
| HDASEEYKHRMHNLC | 126 | Q9H0R3 | |
| HMYAHSGEHHLFRCN | 276 | Q9P2F9 | |
| AFSQTSCLIQHHKMH | 416 | Q8N720 | |
| CGHTLHIDCHKSYME | 1326 | Q6ZT12 | |
| SAHAIKHAKAYCCSM | 361 | Q5T0B9 | |
| HRSHMSEKAYQCSEC | 256 | P17020 | |
| FSTAELLCMHYTDHH | 1856 | Q96JM2 | |
| FCSHHSSSLMKNVAH | 256 | Q969S3 | |
| MHQKFHTGKRHYTCS | 296 | Q9HCX3 | |
| EAMEAHHKSHYAFHC | 331 | P52746 | |
| NTLHMMYHEATACHV | 2976 | Q70CQ2 | |
| FCMLSHKTQHKSIYH | 191 | O75437 |